Replies to post #23251 on $Bob's and Jbem's Bitchin' Bios

[value1008]

ITEK - this one should start moving up as we get closer to that mid-year report on results for the combined trial of their drug with Latanoprost-- it was stated by mgmt that the combination market is the really YUGE market.